Mann agreed to participate in the study, called a clinical trial, took Imatinib over four years, and helped doctors discover a viable treatment for CML that extended his life. “There are close to a ...
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...